SK

Sridhar Kondabathula

Active Director Director DIN 08032961
DIN 08032961 First appointment Jan 2018 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2018
Shareholding value •••• Premium profile

About Sridhar Kondabathula

Data last updated:

Sridhar Kondabathula is a Director at Brixy Pharmaceuticals Private Limited (since 2018). The company operates in Chemicals. Brixy Pharmaceuticals Private Limited reported revenue of ₹30.7 Lakh (FY 2019).

DIN 08032961
Primary Designation Director
Industry Chemicals
First Appointment 09 Jan 2018
Oldest Company Age 8 yrs
Largest company Brixy Pharmaceuticals Private Limited · ₹30.7 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Jan 20182018₹30.7 Lakh (FY 2019)Active

Board colleagues of Sridhar Kondabathula

NameDINCompanyDesignation
Lavanya Kondabathula08032970Brixy Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Brixy Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sridhar Kondabathula

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sridhar Kondabathula

Sridhar Kondabathula currently holds 1 directorship: Brixy Pharmaceuticals Private Limited (Director, since 09 Jan 2018, revenue ₹30.7 Lakh (FY 2019)).

Sridhar Kondabathula was first appointed on 09 Jan 2018 as Director at Brixy Pharmaceuticals Private Limited.

The current boards of Sridhar Kondabathula's companies include Lavanya Kondabathula (Brixy Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available